Logo image of ALCHI.PA

ALCHIMIE SAS (ALCHI.PA) Stock Fundamental Analysis

EPA:ALCHI - Euronext Paris - Matif - FR0014000JX7 - Common Stock - Currency: EUR

0.06  -0.01 (-17.81%)

Fundamental Rating

1

Overall ALCHI gets a fundamental rating of 1 out of 10. We evaluated ALCHI against 49 industry peers in the Entertainment industry. ALCHI may be in some trouble as it scores bad on both profitability and health. ALCHI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALCHI has reported negative net income.
ALCHI had a negative operating cash flow in the past year.
In the past 5 years ALCHI always reported negative net income.
In multiple years ALCHI reported negative operating cash flow during the last 5 years.
ALCHI.PA Yearly Net Income VS EBIT VS OCF VS FCFALCHI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M -4M -6M -8M

1.2 Ratios

Looking at the Return On Assets, with a value of -16.93%, ALCHI is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
ROA -16.93%
ROE N/A
ROIC N/A
ROA(3y)-18.81%
ROA(5y)-17.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCHI.PA Yearly ROA, ROE, ROICALCHI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 200 400 600 800 1K

1.3 Margins

ALCHI has a Operating Margin (0.89%) which is in line with its industry peers.
ALCHI has a Gross Margin (60.80%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALCHI has remained more or less at the same level.
Industry RankSector Rank
OM 0.89%
PM (TTM) N/A
GM 60.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.1%
GM growth 5Y-0.12%
ALCHI.PA Yearly Profit, Operating, Gross MarginsALCHI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

ALCHI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALCHI has more shares outstanding
The number of shares outstanding for ALCHI has been reduced compared to 5 years ago.
The debt/assets ratio for ALCHI is higher compared to a year ago.
ALCHI.PA Yearly Shares OutstandingALCHI.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALCHI.PA Yearly Total Debt VS Total AssetsALCHI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -2.14, we must say that ALCHI is in the distress zone and has some risk of bankruptcy.
ALCHI has a worse Altman-Z score (-2.14) than 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.14
ROIC/WACCN/A
WACC0.69%
ALCHI.PA Yearly LT Debt VS Equity VS FCFALCHI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

ALCHI has a Current Ratio of 0.56. This is a bad value and indicates that ALCHI is not financially healthy enough and could expect problems in meeting its short term obligations.
ALCHI's Current ratio of 0.56 is on the low side compared to the rest of the industry. ALCHI is outperformed by 71.11% of its industry peers.
ALCHI has a Quick Ratio of 0.56. This is a bad value and indicates that ALCHI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.56, ALCHI is not doing good in the industry: 71.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
ALCHI.PA Yearly Current Assets VS Current LiabilitesALCHI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ALCHI have decreased strongly by -164.19% in the last year.
ALCHI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -48.67%.
ALCHI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -21.80% yearly.
EPS 1Y (TTM)-164.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.04%
Revenue 1Y (TTM)-48.67%
Revenue growth 3Y-26.86%
Revenue growth 5Y-21.8%
Sales Q2Q%-31.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y88.89%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.54%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALCHI.PA Yearly Revenue VS EstimatesALCHI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALCHI.PA Yearly EPS VS EstimatesALCHI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 0 -0.5 -1 -1.5 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALCHI. In the last year negative earnings were reported.
ALCHI is valuated cheaply with a Price/Forward Earnings ratio of 0.34.
100.00% of the companies in the same industry are more expensive than ALCHI, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.76. ALCHI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 0.34
ALCHI.PA Price Earnings VS Forward Price EarningsALCHI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALCHI is valued cheaply inside the industry as 97.78% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.06
ALCHI.PA Per share dataALCHI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCHI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALCHIMIE SAS

EPA:ALCHI (6/26/2025, 7:00:00 PM)

0.06

-0.01 (-17.81%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)01-30 2025-01-30/amc
Earnings (Next)10-23 2025-10-23
Inst Owners0.74%
Inst Owner ChangeN/A
Ins Owners12.14%
Ins Owner ChangeN/A
Market Cap269.40K
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.34
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 1.06
EPS(TTM)-0.42
EYN/A
EPS(NY)0.18
Fwd EY291.83%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS2.52
BVpS-0.85
TBVpS-1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.93%
ROE N/A
ROCE -2.93%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 0.89%
PM (TTM) N/A
GM 60.8%
FCFM N/A
ROA(3y)-18.81%
ROA(5y)-17.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.1%
GM growth 5Y-0.12%
F-Score4
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0.07
Cap/Depr 45.64%
Cap/Sales 5.41%
Interest Coverage 20.2
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z -2.14
F-Score4
WACC0.69%
ROIC/WACCN/A
Cap/Depr(3y)67.28%
Cap/Depr(5y)114.4%
Cap/Sales(3y)5.8%
Cap/Sales(5y)6.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-164.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.04%
EPS Next Y88.89%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-48.67%
Revenue growth 3Y-26.86%
Revenue growth 5Y-21.8%
Sales Q2Q%-31.78%
Revenue Next Year1.54%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-96.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-821.18%
FCF growth 3YN/A
FCF growth 5Y-16.07%
OCF growth 1Y-100%
OCF growth 3YN/A
OCF growth 5Y-14.32%